GGrantIndex
← Leaderboards

Mark G Lesage

Minneapolis Medical Research Fdn, Inc.

$7,842,496
Attributed
$10,498,825
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,498,825 · 8

By mechanism

R01$9,279,725 · 6
U19$1,162,260 · 1
R03$56,840 · 1

Top collaborators

Most similar at Minneapolis Medical Research Fdn, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Nicotine

Research focus

NicotinePsychological ReinforcementAnimalsDoseTobaccoSelf AdministrationAddictionAnimal ModelBehavioralRattusPharmaceutical PreparationsTobacco DependenceCigaretteNicotine ReplacementPre-ClinicalTobacco UseCigarette SmokeElasticityBaseDrug KineticsProceduresExposure ToAreaSelf Stimulation

Grant awards (28)

Effects of maternal e-cigarette aerosol exposure on nicotine's addiction-related behavioral and neurobiological effects in offspring$692,419
R01 · FY2025 · DA · contact PI
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products$633,574
R01 · FY2024 · DA · contact PI
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products$641,826
R01 · FY2023 · DA · contact PI
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products$683,052
R01 · FY2022 · DA · contact PI
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products$702,233
R01 · FY2021 · DA · contact PI
Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products$694,783
R01 · FY2020 · DA · contact PI
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco products$411,165
R01 · FY2020 · DA
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco products$421,054
R01 · FY2019 · DA
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco products$432,553
R01 · FY2018 · DA
Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations$423,477
R01 · FY2018 · DA · contact PI
Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations$64,342
R01 · FY2018 · DA · contact PI
Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations$460,351
R01 · FY2017 · DA · contact PI
Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations$514,144
R01 · FY2016 · DA · contact PI
Animal Models for Assessing the Relative Abuse Liability of Tobacco Products$205,899
U19 · FY2015 · CA · contact PI
Animal Models for Assessing the Relative Abuse Liability of Tobacco Products$299,465
U19 · FY2014 · CA · contact PI
Animal Models for Assessing the Relative Abuse Liability of Tobacco Products$371,592
U19 · FY2013 · CA · contact PI
Determinants of Nicotine Reinforcement Thresholds and Demand Elasticity in Rats$313,141
R01 · FY2013 · DA · contact PI
Determinants of Nicotine Reinforcement Thresholds and Demand Elasticity in Rats$324,479
R01 · FY2012 · DA · contact PI
Animal Models for Assessing the Relative Abuse Liability of Tobacco Products$285,304
U19 · FY2012 · CA · contact PI
Determinants of Nicotine Reinforcement Thresholds and Demand Elasticity in Rats$322,363
R01 · FY2011 · DA · contact PI
Determinants of Nicotine Reinforcement Thresholds and Demand Elasticity in Rats$305,466
R01 · FY2010 · DA · contact PI
Determinants of Nicotine Reinforcement Thresholds and Demand Elasticity in Rats$331,213
R01 · FY2009 · DA · contact PI
Modeling Behavioral Treatments for Stimulant Abuse$185,345
R01 · FY2009 · DA · contact PI
Modeling Behavioral Treatments for Stimulant Abuse$184,006
R01 · FY2008 · DA · contact PI
Modeling Behavioral Treatments for Stimulant Abuse$186,436
R01 · FY2007 · DA · contact PI
Modeling Behavioral Treatments for Stimulant Abuse$190,678
R01 · FY2006 · DA · contact PI
Modeling Behavioral Treatments for Stimulant Abuse$161,625
R01 · FY2005 · DA
Modeling Behavioral Treatments for Nicotine Dependence$56,840
R03 · FY2001 · DA